Prognostic Impact of Cytogenetic Abnormalities in Adult Patients with Philadelphia-Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Who Underwent Allogeneic Stem Cell Transplant (allo-SCT)

被引：0

作者：

Shimizu, Hiroaki ^{[1
,2
]}

Saitoh, Takayuki ^{[3
]}

Okamoto, Shinichiro ^{[4
]}

Kanda, Yoshinobu ^{[5
]}

Kanamori, Heiwa ^{[6
]}

Takahashi, Satoshi ^{[7
]}

Ohashi, Kazuteru ^{[8
]}

Usuki, Kensuke ^{[9
]}

Nakaseko, Chiaki ^{[10
]}

Onizuka, Makoto ^{[11
]}

Sakura, Toru ^{[12
]}

Goto, Moritaka ^{[13
]}

Yano, Shingo ^{[14
]}

Fujisawa, Shin ^{[15
]}

Watanabe, Reiko ^{[16
]}

Aotsuka, Nobuyuki ^{[17
]}

Taguchi, Jun ^{[18
]}

Tomita, Naoto ^{[19
]}

Wakita, Hisashi ^{[17
]}

Nannya, Yasuhito ^{[20
]}

机构：

[1] Gunma Univ Hosp, Ctr Oncol, Gunma, Japan

[2] Kanto Study Grp Cell Therapy, Tokyo, Japan

[3] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Gunma, Japan

[4] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan

[5] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan

[6] Kanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa 2410815, Japan

[7] Univ Tokyo, Inst Med Sciece, Adv Clin Res Ctr, Div Mol Therapy, Tokyo, Japan

[8] Tokyo Metropolitan Komagome Hosp, Div Hematol, Tokyo, Japan

[9] NTT Med Ctr Tokyo, Dept Hematol, Tokyo, Japan

[10] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan

[11] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan

[12] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Gunma, Japan

[13] Tokyo Med Univ Hosp, Div Hematol, Tokyo, Japan

[14] Jilkei Univ, Tokyo, Japan

[15] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 232, Japan

[16] Saitama Med Univ, Saitama Med Ctr, Dept Hematol, Kawagoe, Saitama, Japan

[17] Japanese Red Cross Narita Hosp, Dept Hematol & Oncol, Narita, Japan

[18] Shizuoka Red Cross Hosp, Hematol, Shizuoka, Japan

[19] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 232, Japan

[20] Univ Tokyo, Hematol & Oncol, Tokyo, Japan

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] A nine-gene predictor of therapy response in adult Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph plus ALL)
Zuo, Z.
Jones, D. M.
Thomas, D. A.
O'Brien, S.
Ravandi, F.
Kantarjian, H. M.
Medeiros, L. J.
Luthra, R.
Chen, S. S.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[42] IMATINIB AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) FOR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH plus ALL): INTERIM ANALYSIS OF A RANDOMIZED PHASE III STUDY
Ottmann, G.
Wassmann, B.
Pfeifer, H.
Bornhaeuser, M.
Bethge, W.
Dengler, J.
Stadler, M.
Beelen, D. W.
Basara, N.
Schwerdtfeger, R.
Schaefer-Eckhart, K.
Uharek, L.
Stelljes, M.
Serve, H.
Hoelzer, D.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 196 - 196
[43] The impact of tyrosine kinase inhibitors on allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Zhang, Yuanfeng
Feng, Sizhou
LEUKEMIA RESEARCH, 2021, 109
[44] A randomized study comparing two schedules of Imatinib Intervention after allogeneic stem cell transplantation (SCT) for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph plus ALL)
Pfeifer, H.
Wassmann, B.
Bethge, W.
Dengler, J.
Bornhaeuser, M.
Stadler, M.
Beelen, D.
Guenther, A.
Vucinic, V.
Burmeister, T.
Stelljes, M.
Schwerdtfeger, R.
Schaefer-Eckhart, K.
Bader, P.
Kreyenberg, H.
Schuld, P.
Serve, H.
Hoelzer, D.
Goekbuget, N.
Ottmann, O. G.
ONKOLOGIE, 2011, 34 : 15 - 16
[45] Selinexor Maintenance Is Feasible and Tolerable after Allogeneic Stem Cell Transplant (allo-SCT) for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Liu, Hongtao
Artz, Andrew
Larson, Richard A.
Kosuri, Satyajit
Stock, Wendy
Bishop, Michael R.
BLOOD, 2017, 130
[46] Prognostic Index for Survival in Adult Patients with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia (ALL)
Yilmaz, Musa
Kantarjian, Hagop M.
Wang, Xuemei
Devendra, K. C.
Khoury, Joseph David
Ravandi, Farhad
Short, Nicholas J.
Cortes, Jorge E.
Garcia-Manero, Guillermo
Kadia, Tapan
Sasaki, Koji
Konopleva, Marina
Wierda, William G.
Khouri, Maria
Jain, Nitin
Verstovsek, Srdan
Estrov, Zeev
Bose, Prithviraj
Pierce, Sherry
Garris, Rebecca
O'Brien, Susan M.
Jabbour, Elias J.
BLOOD, 2017, 130
[47] Outcomes of second allogeneic hematopoietic stem cell transplantation (SCT) for patients with acute lymphoblastic leukemia (ALL)
Poon, L. M.
Bassett, Roland
Rondon, Gabriela
Worth, Laura L.
Cooper, Laurence
Popat, Uday R.
Nieto, Yago
De Lima, Marcos J. G.
Champlin, Richard E.
Kebriaei, Partow
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[48] Reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) for patients with acute lymphoblastic leukemia (ALL): A survey from the European group for blood and marrow transplantation (EBMT).
Mohty, M
Labopin, M
Boiron, JM
Theorin, N
Fauser, A
Rambaldi, A
Boogaerts, M
Slavin, S
Majolino, I
Blaise, D
Rocha, V
BLOOD, 2005, 106 (11) : 195A - 195A
[49] Allogeneic Hematopoietic Stem Cell Transplant Versus No Transplant in Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission and Complete Molecular Remission
Ghobadi, Armin
Mohammed, Kahee A.
Faramand, Rawan
Kantarjian, Hagop M.
Jabbour, Elias
Short, Nicholas J.
Gao, Feng
Uy, Geoffrey L.
Westervelt, Peter
DiPersio, John F.
Champlin, Richard E.
Ravandi, Farhad
Kebriaei, Partow
BLOOD, 2020, 136
[50] Prognostic significance of complex karyotype in philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (all) in adults
Granada, J. M. Hernandez-Rivas
Duarte, J. J.
Sole, F.
Ortega, M.
Ferro, T.
Marugan, I.
Cervera, J.
Martin Ramos, M. L.
Ribera, J. M.
CHROMOSOME RESEARCH, 2007, 15 : 219 - 220

← 1 2 3 4 5 →